arrow
Back
M

Matthias Preusser

Medical University of Vienna

96H-index
1.1KPaper Count
4.4WCitation Count
Published Papers 463
Publication Date
Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors
err2026-10-14
err0
PREAI
errVincent Sunder-Plassmann; Philipp Melhorn; Angelika Martina Starzer; Julia Maria Berger; Lynn Gottmann; Martin Korpan; Markus Kleinberger; Isabella Solano Henao; Josef Fürst; Nikola Vladic; Cihan Ay; Tanja Stamm; Matthias Preusser; Gerwin Heller; Anna Sophie Berghoff
errShare
errSave
Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors
err2026-09-30
err0
errOAAI
errLeyla Ay; Ingrid Pabinger; Matthias Preusser; Anna Sophie Berghoff; Christoph Hoeller; Cihan Ay; Florian Moik
errShare
errSave
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma
err2026-09-08
err0
PREAI
errAbigirl Machingura; Johannes Weller; Johan A F Koekkoek; Linda Dirven; Matthias Preusser; Patrick Roth; Roger Stupp; Michael Weller; Madeline Pe; Thierry Gorlia; Martin J B Taphoorn; Emilie Le Rhun; Clemens Seidel; EORTC Brain Tumour Group
errShare
errSave
Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes
err2026-08-27
err0
errOAAI
errEleonora Camilleri; Nikola Vladic; Cornelia Englisch; Daniel Steiner; Matthias Preusser; Anna S. Berghoff; Thorsten Fuereder; Julia M. Berger; L. Renee Ruhaak; Suzanne C. Cannegieter; Bart J.M. van Vlijmen; Frederikus A. Klok; Cihan Ay
errShare
errSave
ESTRO, ESNR, and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumors
err2026-08-20
err0
PREAI
errLieselotte Lauwens; Catharina M L Zegers; Alida A Postma; Giuseppe Minniti; Claire Alapetite; Nicolaus Andratschke; Anna Sophie Berghoff; Malin Blomstrand; Thomas C Booth; Antonella Castellano; Anthony J Chalmers; Jan W Dankbaar; Anna Falk Delgado; Johnny Duerinck; Felix Ehret; Sara C Erridge; Enrico Franceschi; Julia Furtner; Norbert Galldiks; Semi B Harrabi; Morten Høyer; Alberto Iannalfi; Tomas Kazda; Emilie Le Rhun; Ulrike Löbel; Giuseppe Lombardi; Carola Lütgendorf-Caucig; Kshitij Mankad; Pierina Navarria; Maximilian Niyazi; Teresa Nunes; Albert Pons-Escoda; Matthias Preusser; Ana Ramos; Evangelia Razis; Erik Roelofs; Roberta Rudà; Julien Savatovsky; Juan M Sepúlveda; Pia C Sundgren; Beate Timmermann; Esther G C Troost; Anouk Van der Hoorn; Damien Charles Weber; Michael Weller; Martin J van den Bent; Maarten Lambrecht; Marion Smits; Daniëlle B P Eekers
errShare
errSave
Exploring the landscape of targetable alterations in patients with glioblastoma
err2026-08-19
err0
PREAI
errElisa Aquilanti; Mehdi Touat; Pim French; Antonio Iavarone; David Capper; Marjolein Geurts; Rifaquat Rahman; Roel Verhaak; Matthias Preusser; Martin van den Bent; Patrick Y. Wen
errShare
errSave
PET RANO 1.0 vs RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: A retrospective, comparative study
err2026-08-14
err0
PREAI
errKatharina J Schmidbauer; Isabelle von Polenz; Jonas Reis; Lilian Wiegand; Maximilian J Mair; Thedora Aras; Jera Isakaj; Thomas Schabhüttl; Enio Barci; Robert Forbrig; Lena Kaiser; Rudolf A Werner; Florian Ringel; Stephan Schönecker; Veit M Stöcklein; Tobias Greve; Patrick Harter; Louisa von Baumgarten; Matthias Preusser; Nathalie L Albert
errShare
errSave
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy
err2026-08-01
err0
PREAI
errSteindl, Ariane; Starzer, Angelika M.; Tomasich, Erwin; Kleinberger, Markus; Berchtold, Luzia; Eckert, Franziska; Widhalm, Georg; Gatterbauer, Brigitte; Hainfellner, Johannes A.; Wozelka-Oltjan, Lisa; Erguener, Bekir; Schuster, Michael; Bock, Christoph; Heller, Gerwin; Preusser, Matthias; Berghoff, Anna. S.
errShare
errSave
Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency department
err2026-05-27
err0
errOAAI
errMarkus Kleinberger; Petar Popov; Anna Pfarrhofer; Sabina Pasalic; Sandra Mayer; Daniel Kogler; Filippo Cacioppo; Thorsten Fuereder; Markus Raderer; Thomas Brodowicz; Rupert Bartsch; Gerald Prager; Matthias Preusser; Christoph Minichsdorfer
errShare
errSave
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification
err2026-02-09
err0
errOAAI
errSybren L. N. Maas; Yiheng Tang; Eric Stutheit-Zhao; Ramin Rahmanzade; Christina Blume; Thomas Hielscher; Ferdinand Zettl; Salvatore Benfatto; Domenico Calafato; Martin Sill; Jasim Kada Benotmane; Yahaya A. Yabo; Felix Behling; Abigail Suwala; Helin Kardo; Michael Ritter; Matthieu Peyre; Roman Sankowski; Konstantin Okonechnikov; Philipp Sievers; Areeba Patel; David Reuss; Mirco J. Friedrich; Damian Stichel; Daniel Schrimpf; Thierry P. P. Van den Bosch; Katja Beck; Hans-Georg Wirsching; Gerhard Jungwirth; C. Oliver Hanemann; Katrin Lamszus; Nima Etminan; Andreas Unterberg; Christian Mawrin; Marc Remke; Olivier Ayrault; Peter Lichter; Guido Reifenberger; Michael Platten; Tim Kacprowski; Markus List; Josch K. Pauling; Jan Baumbach; Till Milde; Rachel Grossmann; Zvi Ram; Miriam Ratliff; Jan-Philipp Mallm; Marian C. Neidert; Eelke M. Bos; Marco Prinz; Michael Weller; Till Acker; Felix J. Hartmann; Matthias Preusser; Ghazaleh Tabatabai; Christel Herold-Mende; Sandro M. Krieg; David T. W. Jones; Stefan M. Pfister; Wolfgang Wick; Michel Kalamarides; Andreas von Deimling; Dieter Henrik Heiland; Volker Hovestadt; Moritz Gerstung; Matthias Schlesner; Felix Sahm
errShare
errSave
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma
err2026-01-09
err0
PREAI
errEmilie Le Rhun; Debaleena Sain; Martin van den Bent; Enrico Franceschi; Ghazaleh Tabatabai; Wolfgang Wick; Matthias Preusser; Thierry Gorlia; Michael Weller
errShare
errSave
From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials
err2026-01-01
err0
PREAI
errTolboom, Nelleke; Albert, Nathalie L.; Braat, Arthur J. A. T.; Snijders, Tom J.; Tabouret, Emeline; Taillandier, Luc; Brendel, Matthias; Cecchin, Diego; Aguiar-Fernandez, Pablo; Fraioli, Francesco; Guedj, Eric; Traub-Weidinger, Tatjana; Yakushev, Igor; Van Weehaeghe, Donatienne; Preusser, Matthias; Verger, Antoine
errShare
errSave
Drawing parallels between amyloid PET in Alzheimer's disease and amino acid PET in primary and secondary brain tumors
err2026-01-01
err0
PREAI
errTolboom, Nelleke; Verger, Antoine; Preusser, Matthias; Geurts, Marjolein; Scheltens, Philip; Albert, Nathalie Lisa
errShare
errSave
Targeted therapies in optic pathway gliomas
err2025-12-27
err0
errOAAI
errEdoardo Agosti; Pier Paolo Panciani; Giuseppe Lombardi; Matthias Preusser; Giorgia De Rosa; Karen Mapelli; Amedeo Piazza; Daniele Tognetto; Caterina Gagliano; Luca Denaro; Marta Padovan; Marco Maria Fontanella; Marco Zeppieri; Tamara Ius
errShare
errSave
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges
err2025-12-22
err0
errOAAI
errZoltan Spiro; Amin El-Heliebi; Maximilian J. Mair; Thomas R. Pieber; Barbara Prietl; Sabine Spiegl-Kreinecker; Stefanie Stanzer; Adelheid Wöhrer; Matthias Preusser; Anna Sophie Berghoff
errShare
errSave
The evolving landscape of brain metastasis: volume II
err2025-12-02
err0
errOAAI
errManuel Valiente; Carey Anders; Adrienne Boire; Benjamin Izar; Nuria Kotecki; Srinivas Malladi; Joan Massagué; Nelson S. Moss; Josh Neman; Matthias Preusser; Sanne Schagen; Peter M. Siegel; Hussein Tawbi; Varun Venkataramani; Frank Winkler; Gelareh Zadeh; Johanna A. Joyce
errShare
errSave
Methodological aspects of economic evaluations and health economic models in glioblastoma: A systematic literature review
err2025-12-01
err0
errOAAI
errOrszagh, Erika; Jozwiak-Hagymasy, Judit; Doczi, Tamas; Mezei, Dora; Nemeth, Bertalan; Varga, Hedi; Tordai, Attila; Kazda, Tomas; Gorlia, Thierry; Quoilin, Caroline; Preusser, Matthias; Minniti, Giuseppe; Csanadi, Marcell
errShare
errSave
Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma
err2025-11-18
err0
errOAAI
errJan-Michael Werner; Maximilian J. Mair; Michael M. Wollring; Enio Barci; Isabelle Stetter; Hannah C. Puhr; Caroline Tscherpel; Gabriele Stoffels; Johannes A. Hainfellner; Anna S. Berghoff; Vincent Sunder-Plassmann; Georg Widhalm; Franziska Eckert; Gregor Kasprian; Thomas S. Nakuz; Alexander Beck; Patrick N. Harter; Louisa von Baumgarten; Niklas Thon; Stephan Schönecker; Robert Forbrig; Felix M. Mottaghy; Philipp Lohmann; Gereon R. Fink; Karl-Josef Langen; Norbert Galldiks; Nathalie L. Albert; Matthias Preusser
errShare
errSave
CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)
err2025-11-11
err0
errOAAI
errMarjolein Geurts; Emilie LeRhun; Giuseppe Minniti; Marta Padovan; Johnny Duerinck; Enrico Franceschi; Mehdi Touat; Andrea Pace; Felix Sahm; Julia Furtner; Nathalie Albert; Philipp Lohman; Martine van Zandvoort; Caroline Quoilin; Corinne Daumer; Eng-Siew Koh; Marshall Pitz; Thierry Gorlia; Michael Weller; Martin van den Bent; Matthias Preusser
errShare
errSave
Application of the PET RANO 1.0 criteria in diffuse glioma: a retrospective, single-center, real-world experience
err2025-11-01
err0
errOAAI
errWiegand, Lilian; Muller, Katharina; Mair, Maximilian; Barci, Enio; Von Baumgarten, Louisa; Harter, Patrick; Brendel, Matthias; Preusser, Matthias; Forbrig, Robert; Greve, Tobias; Schonecker, Stephan; Albert, Nathalie
errShare
errSave